Group One Trading, L.P. Ascendis Pharma A/S Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Group One Trading, L.P. holds 4,101 shares of ASND stock, worth $676,172. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,101Holding current value
$676,172% of portfolio
0.02%Shares
19 transactions
Others Institutions Holding ASND
# of Institutions
238Shares Held
59.6MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.67 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$911 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$841 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$734 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$722 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.2B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...